Allogene Therapeutics, Inc. (ALLO) vs Indaptus Therapeutics, Inc. (INDP)

Allogene Therapeutics, Inc. and Indaptus Therapeutics, Inc. are both Biotechnology companies. Allogene Therapeutics, Inc. and Indaptus Therapeutics, Inc. are of similar size ($606.8M and $594.2M). Indaptus Therapeutics, Inc. has the higher net margin (0.00% vs −3,517.4%) and the higher return on invested capital (0.00% vs −108.8%). Across the 13 metrics below, Indaptus Therapeutics, Inc. leads on 8 and Allogene Therapeutics, Inc. on 5.

Valuation

Metric ALLO INDP Biotechnology median
P/E n/m n/m 7.88
P/S 115.35 n/m 11.47
P/B 1.24 38.60 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 44.66 n/m 10.73
Earnings yield (40.61%) (167.34%) (28.84%)
Free cash flow yield (18.90%) (3.35%) (23.03%)

Profitability

Metric ALLO INDP Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (3,832.45%) 0.00% 0.00%
Net margin (3,517.41%) 0.00% 0.00%
Free cash flow margin (2,180.62%) 0.00% 0.00%
Return on equity (42.39%) (318.04%) (57.72%)
Return on assets (32.43%) (163.84%) (49.22%)
Return on invested capital (108.81%) 0.00% 0.00%

Growth

Metric ALLO INDP Biotechnology median
Revenue growth (TTM) 7,613.11% — 5.64%
EPS growth (last fiscal year) 34.09% 52.15% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALLO INDP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.72 19.48 4.73
Net debt to EBITDA 1.24 0.43 0.96

Dividend

Metric ALLO INDP Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ALLO INDP Biotechnology median
Market cap 594.24m 606.77m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack